United States · Pharmaceuticals startup
United States · AMAG Pharmaceuticals
AMAG Pharmaceuticals is a biopharmaceutical company that provides solutions for patients with complex, underserved conditions.
Funding reportedLast round: Post ipo debt
What company datasets say AMAG Pharmaceuticals raised
Funding, as reported
Reported in all$475Min dollars
Rounds2
Last roundPost ipo debt
Last round dateMay 2017
Founders and team
From AMAG Pharmaceuticals's own website: 1 founder, 11 on the team.
Rolf HoffmanCEO and Founder NavBio AG
- Michael PorterChief Executive Officer
- Emanuele PizzoVice President, Finance, EU and International
- Janine ListVice President, Head of Business Planning and Analysis
- Christine PoulinPresident, North America & General Manager of Canada
- Albert DahoukChief Information Officer
- Ozgur KilicChief Financial Officer
- Raghav ChariChief Innovation Officer
- Fabio FazioEVP, Global Head of Quality
- Andrew TeehanInterim General Counsel
- Claude NoesenIndependent Non-Executive Fund Director
- Rajiv de SilvaChairman
AdvisersIldiko Mehes
On a portfolio page
Investors who name them
Each firm lists AMAG Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Pharmaceuticals in United States
Startups like it
- PL DevelopmentsWestbury · founded 1988
Remedi SeniorCareBaltimore · founded 1954- Spectrum PharmaceuticalsLake Forest · founded 1987
- moksha8 PharmaceuticalsBerwyn · founded 2007
NeurelisSan Diego · founded 2007
Amplyx PharmaceuticalsSan Diego · founded 2006- Zosano PharmaFremont · founded 2006
Alexza PharmaceuticalsFremont · founded 2001
Is this your company?
Add your raise, your deck and your story, and put AMAG Pharmaceuticals in front of investors. Or tell us what we have wrong.